Enclomiphene and Sermorelin Interaction

Monitor
Mechanism-based 47% confidence

Enclomiphene and Sermorelin have an interaction requiring monitoring for interaction with 47% confidence. Both Enclomiphene and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Both compounds affect the pituitary, so monitoring these systems is recommended.

Compound Profiles

Enclomiphene

Selective Estrogen Receptor Modulator | Testosterone & Fertility Support

Enclomiphene competitively antagonizes estrogen receptors in the hypothalamus and anterior pituitary, blocking the negative feedback of estradiol on GnRH release. This disinhibition increases pulsatile GnRH secretion, which in turn stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Half-life: ~10 hours Typical dose: 12.5-25mg oral daily pct, sexual health
estrogen receptorserotonin receptor hepatotoxicpct agentteratogenic
View full profile

Sermorelin

GHRH Analog | Growth Hormone Releasing Hormone

Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..

Half-life: 10-12 minutes Typical dose: 200-300mcg per dose (up to 500mcg for athletic performance) growth hormone, weight loss
estrogen receptorghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Pituitary
low
Gonads
low
GI Tract
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Enclomiphene, Sermorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Enclomiphene with Sermorelin?

Yes, but with caution. Both Enclomiphene and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Regular monitoring is advised.

Is Enclomiphene and Sermorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Enclomiphene and Sermorelin?

Both Enclomiphene and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Enclomiphene and Sermorelin?

Enclomiphene has a half-life of ~10 hours and Sermorelin has a half-life of 10-12 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Enclomiphene vs Sermorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.